Tre recombinase is an experimental enzyme that in lab tests has removed DNA inserted by HIV from infected cells. [1] Through selective mutation, Cre recombinase which recognizes loxP sites are modified to identify HIV long terminal repeats (loxLTR) instead. As a result, instead of performing Cre-Lox recombination, the new enzyme performs recombination at HIV provirus sites. [2]
The structure of Tre in complex with loxLTR has been resolved ( PDB: 5U91), allowing for analyzing the roles of individual mutations. [3]
References
- ^ Sarkar, Indrani; Hauber, Ilona; Hauber, Joachim; Buchholz, Frank (2007). "HIV-1 proviral DNA excision using an evolved recombinase". Science. 316 (5833): 1912–15. Bibcode: 2007Sci...316.1912S. doi: 10.1126/science.1141453. PMID 17600219. S2CID 2437602.
- ^ Hauber, Ilona; Hofmann-Sieber, Helga; Chemnitz, Jan; et al. (September 26, 2013). "Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice". PLOS Pathogens. 9 (9): e1003587. doi: 10.1371/journal.ppat.1003587. PMC 3784474. PMID 24086129.
- ^ Meinke, G; Karpinski, J; Buchholz, F; Bohm, A (19 September 2017). "Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA". Nucleic Acids Research. 45 (16): 9726–9740. doi: 10.1093/nar/gkx603. PMC 5766204. PMID 28934476.
External links
- Minkel, JR (June 28, 2007). "Designer enzyme cuts HIV out of infected cells". Scientific American.
 | This genetics article is a stub. You can help Wikipedia by expanding it. |
Tre recombinase is an experimental enzyme that in lab tests has removed DNA inserted by HIV from infected cells. [1] Through selective mutation, Cre recombinase which recognizes loxP sites are modified to identify HIV long terminal repeats (loxLTR) instead. As a result, instead of performing Cre-Lox recombination, the new enzyme performs recombination at HIV provirus sites. [2]
The structure of Tre in complex with loxLTR has been resolved ( PDB: 5U91), allowing for analyzing the roles of individual mutations. [3]
References
- ^ Sarkar, Indrani; Hauber, Ilona; Hauber, Joachim; Buchholz, Frank (2007). "HIV-1 proviral DNA excision using an evolved recombinase". Science. 316 (5833): 1912–15. Bibcode: 2007Sci...316.1912S. doi: 10.1126/science.1141453. PMID 17600219. S2CID 2437602.
- ^ Hauber, Ilona; Hofmann-Sieber, Helga; Chemnitz, Jan; et al. (September 26, 2013). "Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice". PLOS Pathogens. 9 (9): e1003587. doi: 10.1371/journal.ppat.1003587. PMC 3784474. PMID 24086129.
- ^ Meinke, G; Karpinski, J; Buchholz, F; Bohm, A (19 September 2017). "Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA". Nucleic Acids Research. 45 (16): 9726–9740. doi: 10.1093/nar/gkx603. PMC 5766204. PMID 28934476.
External links
- Minkel, JR (June 28, 2007). "Designer enzyme cuts HIV out of infected cells". Scientific American.
|
| This genetics article is a stub. You can help Wikipedia by expanding it. |